Pfizer Inc (PFE)

Receivables turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	63,627,000	58,496,000	100,330,000	81,288,000	41,908,000
Receivables	US$ in thousands	—	—	—	—	—
Receivables turnover		—	—	—	—	—

December 31, 2024 calculation

Receivables turnover = Revenue ÷ Receivables
= $63,627,000K ÷ $—K
= —

The data provided for Pfizer Inc's receivables turnover ratio from December 31, 2020, to December 31, 2024, shows that the exact figures for these years are not available ("\u2014" indicates missing data).

The receivables turnover ratio is a financial metric that measures how efficiently a company is able to collect outstanding receivables from its customers during a specific period. A higher turnover ratio indicates that the company is collecting its receivables more quickly, which is generally seen as a positive sign of efficient operations.

Without the specific numerical data for each year, a proper analysis of Pfizer Inc's receivables turnover performance over the specified period cannot be conducted. It is crucial to have this information to assess the company's effectiveness in managing its accounts receivable and its overall financial health.

For a more comprehensive evaluation and comparison, concrete receivables turnover figures for each year would be necessary to determine trends, identify any potential issues in collections, and gauge the company's financial performance in terms of accounts receivable management.